在BA.5感染后,针对XBB Omicron亚型的中和抗体水平较低

Jingyun Yang1, Weiqi Hong1, Hong Lei1

  • 1Laboratory of Aging Research and Cancer Drug Target, Department of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, Sichuan, 610041, People's Republic of China.

概括

来自Omicron BA.5感染的混合免疫力对较新的XBB亚变体具有有限的保护. 目前的COVID-19疫苗可能需要更新,以有效打击新出现的SARS-CoV-2菌株.